BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15378768)

  • 1. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
    Gao P; Zhou GY; Liu Y; Li JS; Zhen JH; Yuan YP
    World J Gastroenterol; 2004 Oct; 10(20):2936-9. PubMed ID: 15378768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
    Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
    Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.
    Kumari S; Puneet ; Prasad SB; Yadav SS; Kumar M; Khanna A; Dixit VK; Nath G; Singh S; Narayan G
    Med Oncol; 2016 May; 33(5):40. PubMed ID: 27034264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of retinoblastoma and cyclin D1 in gastric carcinoma.
    Arici DS; Tuncer E; Ozer H; Simek G; Koyuncu A
    Neoplasma; 2009; 56(1):63-7. PubMed ID: 19152247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
    J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent amplification of the cyclin E gene in human gastric carcinomas.
    Akama Y; Yasui W; Yokozaki H; Kuniyasu H; Kitahara K; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1995 Jul; 86(7):617-21. PubMed ID: 7559076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers.
    Oda K; Okabayashi T; Kataoka M; Takeda A; Shibuya Y; Orita K; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1999; 105(3):237-52. PubMed ID: 10954128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
    He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
    Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer.
    Aoyagi K; Koufuji K; Yano S; Murakami N; Terasaki Y; Yamasaki Y; Takeda J; Tanaka M; Shirouzu K
    Kurume Med J; 2000; 47(3):199-203. PubMed ID: 11059220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells.
    Shuai XM; Han GX; Wang GB; Chen JH
    World J Gastroenterol; 2006 Mar; 12(11):1766-9. PubMed ID: 16586549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of cyclin D1 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN
    Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.
    Yasui W; Kudo Y; Semba S; Yokozaki H; Tahara E
    Jpn J Cancer Res; 1997 Jul; 88(7):625-9. PubMed ID: 9310133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach.
    Arber N; Gammon MD; Hibshoosh H; Britton JA; Zhang Y; Schonberg JB; Roterdam H; Fabian I; Holt PR; Weinstein IB
    Hum Pathol; 1999 Sep; 30(9):1087-92. PubMed ID: 10492044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 in gastric carcinoma.
    Tong WW; Tong GH; Chen XX; Zheng HC; Wang YZ
    Int J Oncol; 2015 Jan; 46(1):233-42. PubMed ID: 25338835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
    Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
    Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
    Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
    J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.